Lupi A, Rognoni A and Secco GG. Biodegradable versus durable polymer drug eluting stents in coronary artery disease: Insights from a meta-analysis of 5834 patients. Eur J Prev Cardiol 2012. [Epub ahead of print 14 November 2012].
2.
Higgins JPT and Green S (eds). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. The Cochrane Collaboration, www.cochrane-handbook.org (2011, updated March 2011).
3.
StefaniniGGKalesanBSerruysPW. Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomized non-inferiority trial. Lancet2011; 378: 1940–1948.
4.
NavareseEPKubicaJCastriotaF. Safety and efficacy of biodegradable vs. durable polymer drug-eluting stents: Evidence from a meta-analysis of randomized trials. EuroIntervention2011; 7: 985–994.
